ARIAD Pharmaceuticals makes appointments

FRAMINGHAM (11/24/2003) - Paul J. Sekhri has been appointed to the newly created position of president and chief business officer of ARIAD Pharmaceuticals Inc. Previously, Sekhri was senior vice president in the global business development and licensing group at Novartis Pharma. Three senior ARIAD R&D executives were also promoted: Timothy Clackson, now chief scientific officer; John Iuliucci, chief development officer; and Tomi Sawyer, senior vice president of drug discovery.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about ARIAD Pharmaceuticals

Show Comments